To evaluate the role of TGF signalling in high glucose-induced PSC activation, we treated cells in the low-glucose group with 5 ng/mL TGF1 and cells in the high-glucose group with 10 M of the TGF pathway inhibitor SB431542
10.1016/j.neubiorev.2023.105140 302 WestcottW
These include: Nausea (affecting up to 20% of patients initially, usually diminishing over 4-8 weeks) Vomiting and diarrhoea (less common but can occur during dose escalation) Reduced appetite (often considered therapeutically beneficial but may be troublesome for some) Abdominal discomfort or bloating These effects typically improve with continued use
The protein requirements on semaglutide are also important for maintaining muscle mass, including cardiac muscle, during weight loss
In the SURPASS-4 trial, patients receiving tirzepatide experienced an average weight loss of 7.1 kg (15.7 lbs) after 52 weeks, compared to 2.5 kg (5.5 lbs) in the insulin glargine group[6]
Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM (2017) Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery
